Avarieux
back to explore
Structure Therapeutics Inc. logo

GPCR

Structure Therapeutics Inc.
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2023-02-03
$20.35
-0.12 (-0.59%)
last quote
Want the full multi-source brief on GPCR?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$20.35
High
$21.16
Low
$20.30
Previous close
$20.47
Fundamentals
Market cap
$1.56B
P/E (TTM)
—
P/S (TTM)
—
P/B
2.71x
Gross margin
—
Operating margin
—
Net margin
—
Rev growth (YoY)
—
EPS growth (YoY)
—
ROE
-16.89%
52W high
$94.90
52W low
$20.42
Beta
-1.30x
Industry peers
by market cap
NUVB+2.18%PAHC-2.81%INVA-0.43%OCUL+1.34%ETON+0.28%PCRX-0.03%KARD+0.77%OMER+2.47%
Upcoming earnings
next 30 days
2026-11-04todayafter market
Q3 2026EPS est $-0.59
Recent SEC filings
CIK 1888886filing-language history →
42026-09-22reports 2026-09-18
12 KB
1442026-09-21
5 KB
8-K2026-09-08
7,771 KB
42026-09-02reports 2026-09-01
19 KB
42026-08-19reports 2026-08-18
19 KB
42026-08-07reports 2026-08-06
8 KB
Recent news
2026-10-28 → 2026-11-04
Yahoo · 2d
Novo Before Q3 Earnings: How Should Investors Play the Stock?
NVO faces intensifying GLP-1 competition, earnings cuts and pricing pressure, challenging its growth outlook ahead of Q3 results.
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial